Cargando…

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis

Purpose: To study which brain volume measures best differentiate early relapsing MS (RMS) and secondary progressive MS (SPMS) patients and correlate with disability and cognition. To test whether isolated thalamic atrophy at study baseline correlates with NEDA (no evidence of disease activity) at 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hänninen, Katariina, Viitala, Matias, Paavilainen, Teemu, Karhu, Jari O., Rinne, Juha, Koikkalainen, Juha, Lötjönen, Jyrki, Soilu-Hänninen, Merja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509198/ https://www.ncbi.nlm.nih.gov/pubmed/31130911 http://dx.doi.org/10.3389/fneur.2019.00459

Ejemplares similares

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis
por: Sipilä, Jussi OT, et al.
Publicado: (2023)

Grey matter atrophy in patients with benign multiple sclerosis
por: Niiranen, Marja, et al.
Publicado: (2022)

Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
por: Verkkoniemi-Ahola, Auli, et al.
Publicado: (2023)

Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
por: Hänninen, Katariina, et al.
Publicado: (2020)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study
por: Hänninen, K., et al.
Publicado: (2021)

Effects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD
por: Kaskikallio, Alar, et al.
Publicado: (2021)

Medication adherence/persistence among patients with active multiple sclerosis in Finland
por: Lahdenperä, Sanni, et al.
Publicado: (2020)

Comorbid epilepsy in Finnish patients with adult-onset Huntington’s disease
por: Sipilä, Jussi O. T., et al.
Publicado: (2016)

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions
por: Kaipainen, Aku L, et al.
Publicado: (2021)

Parechovirus infection preceding Guillain–Barré syndrome
por: Linden, Saara, et al.
Publicado: (2012)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
por: Pekkala, Timo, et al.
Publicado: (2020)

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2019)

Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability
por: Koikkalainen, Juha, et al.
Publicado: (2012)

Epidemiology of Guillain‐Barré syndrome in Finland 2004–2014
por: Sipilä, Jussi O.T., et al.
Publicado: (2017)

Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions
por: Toppala, Sini, et al.
Publicado: (2019)

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy
por: Rinne, Juha O., et al.
Publicado: (2022)

Subjective vs informant-reported cognitive complaints have differential clinical significance in covert cerebral small vessel disease
por: Arola, Anne, et al.
Publicado: (2023)

Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis
por: Tewarie, Prejaas, et al.
Publicado: (2013)

Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients
por: Santoro, Silvia, et al.
Publicado: (2022)

Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease
por: Rinne, Juha O., et al.
Publicado: (2016)

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis
por: Rotstein, Dalia, et al.
Publicado: (2022)

Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
por: Wolz, Robin, et al.
Publicado: (2011)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment
por: Åivo, J., et al.
Publicado: (2012)

Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
por: Stephen, Ruth, et al.
Publicado: (2019)

NEDA—NEutron Detector Array
por: Valiente-Dobón, J J, et al.
Publicado: (2019)

No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2021)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
por: Menéndez-González, Manuel, et al.
Publicado: (2014)

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

Brain volumes in relation to loneliness and social competence in preadolescents born very preterm
por: Lind, Annika, et al.
Publicado: (2020)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease
por: Lehmann, Manja, et al.
Publicado: (2012)

Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2017)

Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging
por: Holmström, Miia, et al.
Publicado: (2011)

Choroidal Microvasculature Dropout in the Absence of Parapapillary Atrophy in POAG
por: Lee, Eun Ji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_leoun8tu4r8fi82ks2g4lrueta